Royal Bank of Canada
VNDA icon

Royal Bank of Canada’s Vanda Pharmaceuticals VNDA Stock Holding History

Royal Bank of Canada’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,581
Closed -$14K – 7738
2025
Q4 		$14K Sell
1,581
-49,381
-97% -$272K ﹤0.01% 6252
2025
Q3 		$255K Sell
50,962
-5,104
-9% -$23.6K ﹤0.01% 4930
2025
Q2 		$265K Buy
56,066
+353
+0.6% +$1.54K ﹤0.01% 4953
2025
Q1 		$256K Buy
55,713
+14,232
+34% +$66.3K ﹤0.01% 4522
2024
Q4 		$199K Sell
41,481
-5,020
-11% -$24.1K ﹤0.01% 4824
2024
Q3 		$217K Sell
46,501
-11,561
-20% -$62K ﹤0.01% 4756
2024
Q2 		$327K Sell
58,062
-11,118
-16% -$57.4K ﹤0.01% 4349
2024
Q1 		$284K Buy
69,180
+30,395
+78% +$122K ﹤0.01% 4403
2023
Q4 		$164K Sell
38,785
-35,024
-47% -$141K ﹤0.01% 5264
2023
Q3 		$319K Sell
73,809
-1,600
-2% -$8.89K ﹤0.01% 4396
2023
Q2 		$498K Buy
75,409
+6,761
+10% +$43.3K ﹤0.01% 3955
2023
Q1 		$467K Buy
68,648
+46,937
+216% +$330K ﹤0.01% 3918
2022
Q4 		$160K Buy
21,711
+476
+2% +$4.64K ﹤0.01% 5076
2022
Q3 		$210K Buy
21,235
+280
+1% +$2.96K ﹤0.01% 4733
2022
Q2 		$229K Buy
20,955
+49
+0.2% +$508 ﹤0.01% 4708
2022
Q1 		$236K Sell
20,906
-716
-3% -$9.41K ﹤0.01% 4941
2021
Q4 		$340K Sell
21,622
-58
-0.3% -$1.01K ﹤0.01% 4825
2021
Q3 		$372K Buy
21,680
+733
+3% +$12.8K ﹤0.01% 4597
2021
Q2 		$451K Buy
20,947
+19
+0.1% +$340 ﹤0.01% 4376
2021
Q1 		$314K Sell
20,928
-16,106
-43% -$261K ﹤0.01% 4578
2020
Q4 		$487K Sell
37,034
-3,564
-9% -$42.9K ﹤0.01% 4161
2020
Q3 		$393K Buy
40,598
+4,744
+13% +$50.7K ﹤0.01% 4066
2020
Q2 		$411K Buy
35,854
+16,551
+86% +$187K ﹤0.01% 3944
2020
Q1 		$200K Buy
19,303
+17,447
+940% +$216K ﹤0.01% 4333
2019
Q4 		$31K Buy
1,856
+106
+6% +$1.6K ﹤0.01% 5673
2019
Q3 		$23K Sell
1,750
-140
-7% -$1.95K ﹤0.01% 5452
2019
Q2 		$27K Sell
1,890
-12
-0.6% -$191 ﹤0.01% 5567
2019
Q1 		$35K Sell
1,902
-938
-33% -$21.4K ﹤0.01% 5369
2018
Q4 		$74K Buy
2,840
+169
+6% +$3.97K ﹤0.01% 4889
2018
Q3 		$62K Buy
2,671
+28
+1% +$572 ﹤0.01% 5131
2018
Q2 		$50K Sell
2,643
-1,006
-28% -$16.8K ﹤0.01% 5154
2018
Q1 		$61K Sell
3,649
-231
-6% -$3.87K ﹤0.01% 4965
2017
Q4 		$59K Sell
3,880
-3,314
-46% -$49.2K ﹤0.01% 5097
2017
Q3 		$129K Buy
7,194
+3,679
+105% +$61.6K ﹤0.01% 4833
2017
Q2 		$57K Buy
3,515
+9
+0.3% +$130 ﹤0.01% 5051
2017
Q1 		$49K Sell
3,506
-1,174
-25% -$16.7K ﹤0.01% 5172
2016
Q4 		$75K Buy
4,680
+1,180
+34% +$19K ﹤0.01% 5032
2016
Q3 		$58K Buy
3,500
+1,000
+40% +$13.5K ﹤0.01% 5093
2016
Q2 		$28K Sell
2,500
-7,900
-76% -$76.5K ﹤0.01% 5370
2016
Q1 		$87K Sell
10,400
-62
-0.6% -$509 ﹤0.01% 4833
2015
Q4 		$97K Sell
10,462
-2,166
-17% -$21.6K ﹤0.01% 4943
2015
Q3 		$142K Buy
12,628
+5,368
+74% +$65.7K ﹤0.01% 4553
2015
Q2 		$92K Sell
7,260
-1,240
-15% -$13.4K ﹤0.01% 4884
2015
Q1 		$79K Hold
8,500
– – ﹤0.01% 4736
2014
Q4 		$122K Buy
8,500
+500
+6% +$5.92K ﹤0.01% 4637
2014
Q3 		$83K Hold
8,000
– – ﹤0.01% 4708
2014
Q2 		$129K Buy
8,000
+5,300
+196% +$70.6K ﹤0.01% 4417
2014
Q1 		$44K Buy
+2,700
New +$38.4K ﹤0.01% 4908
2013
Q4 		– Sell
-67,084
Closed -$674K – 6161
2013
Q3 		$734K Buy
67,084
+25,484
+61% +$272K ﹤0.01% 3049
2013
Q2 		$336K Buy
+41,600
New +$280K ﹤0.01% 3488

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's VNDA Position: Q1 2026 in Review

Royal Bank of Canada sold out of Vanda Pharmaceuticals (VNDA) in Q1 2026, closing a stake of 1,581 shares — an estimated $14K sold.

Royal Bank of Canada first reported a position in VNDA in Q2 2013 and held it in 50 quarters. The position peaked at $734K in Q3 2013. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Royal Bank of Canada reported no remaining Vanda Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 1,581 Vanda Pharmaceuticals shares in Q1 2026, an estimated $14K.
  • Royal Bank of Canada first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 50 quarters.
  • Royal Bank of Canada's Vanda Pharmaceuticals position peaked at $734K in Q3 2013.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.